Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B Read more about Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B
Labcorp Announces 2024 First Quarter Results Read more about Labcorp Announces 2024 First Quarter Results
Labcorp Announces Winning Bid for Select Assets of Invitae Read more about Labcorp Announces Winning Bid for Select Assets of Invitae
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw Read more about Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw
Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit Read more about Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit
Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs Read more about Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs
Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research Read more about Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research
Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer Research Read more about Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer Research
Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business Read more about Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business